Zoledronic acid increases the expression of IL-1β in an NLRP3/caspase-1-dependent manner in LPS-primed BMDMs from mice with diabetes mellitus, and NLRP3 inhibitors improve oral wound healing and suppress osteonecrosis of the jaw in these mice (127). This evidence concerns the gene NLRP3 and diabetes mellitus.